X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2996) 2996
Book Review (282) 282
Publication (101) 101
Newsletter (23) 23
Conference Proceeding (13) 13
Magazine Article (10) 10
Book Chapter (7) 7
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2699) 2699
humans (2562) 2562
female (1687) 1687
male (1666) 1666
busulfan - therapeutic use (1509) 1509
adult (1310) 1310
middle aged (1193) 1193
hematology (1082) 1082
busulfan (1040) 1040
transplantation (947) 947
oncology (849) 849
adolescent (793) 793
busulfan - administration & dosage (758) 758
aged (648) 648
child (625) 625
immunology (587) 587
antineoplastic combined chemotherapy protocols - therapeutic use (553) 553
bone-marrow-transplantation (501) 501
transplantation conditioning - methods (499) 499
child, preschool (475) 475
treatment outcome (462) 462
busulfan - adverse effects (447) 447
cyclophosphamide (441) 441
stem cells (440) 440
transplantation, homologous (422) 422
bone marrow transplantation (414) 414
hematopoietic stem cells (408) 408
hematopoietic stem cell transplantation (402) 402
cyclophosphamide - therapeutic use (399) 399
leukemia, myeloid - drug therapy (362) 362
chemotherapy (360) 360
retrospective studies (348) 348
combined modality therapy (345) 345
leukemia (338) 338
cyclophosphamide - administration & dosage (324) 324
infant (320) 320
abridged index medicus (310) 310
stem-cell transplantation (310) 310
vidarabine - analogs & derivatives (297) 297
hematopoietic stem cell transplantation - methods (294) 294
animals (288) 288
survival analysis (287) 287
disease-free survival (273) 273
children (272) 272
cancer (250) 250
total-body irradiation (250) 250
graft vs host disease - prevention & control (247) 247
immunosuppressive agents - therapeutic use (246) 246
follow-up studies (241) 241
pharmacokinetics (239) 239
transplantation conditioning (239) 239
young adult (235) 235
antineoplastic agents - therapeutic use (233) 233
therapy (233) 233
transplantation, autologous (233) 233
hematopoietic stem cell transplantation - adverse effects (225) 225
versus-host-disease (217) 217
survival rate (216) 216
bone-marrow transplantation (215) 215
time factors (215) 215
care and treatment (211) 211
risk factors (210) 210
stem cell transplantation (209) 209
whole-body irradiation (209) 209
prognosis (201) 201
health aspects (199) 199
recurrence (198) 198
remission induction (189) 189
bone marrow (185) 185
hematology, oncology and palliative medicine (185) 185
analysis (182) 182
mice (176) 176
busulfan - pharmacokinetics (175) 175
acute myeloid-leukemia (171) 171
leukemia, myeloid, acute - therapy (171) 171
pharmacology & pharmacy (171) 171
hydroxyurea - therapeutic use (170) 170
toxicity (168) 168
transplantation conditioning - adverse effects (168) 168
research (164) 164
fludarabine (163) 163
pediatrics (160) 160
leukemia, myeloid - therapy (157) 157
busulfan - analogs & derivatives (153) 153
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (153) 153
vidarabine - therapeutic use (153) 153
dose-response relationship, drug (150) 150
dosage and administration (148) 148
graft vs host disease - etiology (147) 147
antineoplastic combined chemotherapy protocols - adverse effects (146) 146
antineoplastic agents, alkylating - therapeutic use (144) 144
chronic myelogenous leukemia (144) 144
mortality (144) 144
leukemia, myelogenous, chronic, bcr-abl positive - therapy (140) 140
survival (140) 140
vidarabine - administration & dosage (139) 139
melphalan - administration & dosage (137) 137
myeloablative agonists - therapeutic use (136) 136
cyclophosphamide - adverse effects (134) 134
busulfan - pharmacology (124) 124
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2619) 2619
German (102) 102
French (62) 62
Spanish (44) 44
Japanese (43) 43
Russian (39) 39
Chinese (31) 31
Polish (30) 30
Italian (25) 25
Dutch (8) 8
Hebrew (5) 5
Portuguese (5) 5
Hungarian (4) 4
Norwegian (4) 4
Czech (3) 3
Romanian (3) 3
Danish (2) 2
Finnish (1) 1
Korean (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Leukemia, ISSN 0887-6924, 02/2015, Volume 29, Issue 2, pp. 396 - 405
Journal Article
Annals of Oncology, ISSN 0923-7534, 2011, Volume 22, Issue 5, pp. 1221 - 1227
Journal Article
by Vellenga, Edo and van Putten, Wim and Ossenkoppele, Gert J and Verdonck, Leo F and Theobald, Matthias and Cornelissen, Jan J and Huijgens, Peter C and Maertens, Johan and Gratwohl, Alois and Schaafsma, Ron and Schanz, Urs and Graux, Carlos and Schouten, Harry C and Ferrant, Augustin and Bargetzi, Mario and Fey, Martin F and Löwenberg, Bob and Ferrant, A and Delannoy, A and Maertens, J and Verhoef, G and Bosly, A and Graux, C and Breems, D. A and Zachee, P and Mineur, P and Jaeger, E and Theobald, M and Beck, J and Fischer, Th and Bargetzi, M and Wernli, M and Gratwohl, A and Fey, M. F and Pabst, T and Chapuis, B and Chalandon, Y and Herr, A and Wuillemin, W. A and Gregor, M and Jacky, E and Schanz, U and Leoncini-Francini, L and Marini, G and Piquet, D and Zimmerli-Schwab, B and Hess, U and Binder, D and Kroner, Th and Wittebol, S and van der Lelie, J and Biemond, B. J and Leeksma, O. C and Ossenkoppele, G. J and Huijgens, P. C and Soesan, M and Wijermans, P. W and Schaafsma, M. R and Legdeur, M and Vellenga, E and Daenen, S. M. G. J and Voogt, P. J and Schouten, H. C and Biesma, D. H and de Weerdt, O and Löwenberg, B and Cornelissen, J. J and Sonneveld, P and Zijlmans, J and Jongen-Lavrencic, M and de Greef, G. E and Verdonck, L. F and Kuball, J and van Marwijk Kooy, M and Dutch-Belgian Hematooncology Coope and Swiss Grp Clinical Canc Res Collab and Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research Collaborative Group (SAKK) and for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), and Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)
Blood, ISSN 0006-4971, 2011, Volume 118, Issue 23, pp. 6037 - 6042
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 576 - 585
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 6, pp. 1046 - 1053
Abstract There are limited data to guide the choice of high-dose therapy (HDT) regimen before autologous hematopoietic cell transplantation (AHCT) for patients... 
Hematology, Oncology and Palliative Medicine | Idiopathic pneumonia syndrome | Autologous transplantation | Lymphoma | RISK-FACTORS | PROGNOSTIC-FACTORS | SPANISH COOPERATIVE GROUP | CYCLOPHOSPHAMIDE | BONE-MARROW-TRANSPLANTATION | Idiopathic pneumonia | PREPARATIVE REGIMENS | IMMUNOLOGY | CHEMOTHERAPY | TRANSPLANTATION | ETOPOSIDE | syndrome | DISEASE | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | Myeloablative Agonists - therapeutic use | Lymphoma, Non-Hodgkin - immunology | Whole-Body Irradiation | Cytarabine - therapeutic use | Hodgkin Disease - pathology | Humans | Middle Aged | Male | Transplantation, Autologous | Melphalan - therapeutic use | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Carmustine - therapeutic use | Aged, 80 and over | Hodgkin Disease - mortality | Adult | Female | Registries | Retrospective Studies | Transplantation Conditioning - methods | Busulfan - therapeutic use | Drug Administration Schedule | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Hodgkin Disease - therapy | Adolescent | Survival Analysis | Hodgkin Disease - immunology | Aged | Lymphoma, Non-Hodgkin - mortality | Care and treatment | Patient outcomes | Analysis | Mortality | Lymphomas | Transplantation | Hematopoietic stem cells | Index Medicus | idiopathic pneumonia syndrome | autologous transplant | lymphoma
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2012, Volume 23, Issue 11, pp. 2970 - 2976
The Italian Sarcoma Group and the Scandinavian Sarcoma Group designed a joint study to improve the prognosis for patients with Ewing's family tumors and... 
Lung metastases | Total-lung irradiation | High-dose chemotherapy | Ewing's sarcoma | STEM-CELL RESCUE | STANDARD CHEMOTHERAPY | PROGNOSTIC-FACTORS | lung metastases | SURVIVAL ANALYSIS | NEUROECTODERMAL TUMORS | CHILDRENS-ONCOLOGY-GROUP | total-lung irradiation | ONCOLOGY | TERM-FOLLOW-UP | BONE | INTERGROUP | high-dose chemotherapy | Myeloablative Agonists - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Bone Neoplasms - therapy | Sarcoma, Ewing - therapy | Humans | Bone Neoplasms - secondary | Child, Preschool | Lung Neoplasms - radiotherapy | Male | Antineoplastic Agents - therapeutic use | Melphalan - therapeutic use | Cyclophosphamide - therapeutic use | Stem Cell Transplantation | Young Adult | Lung Neoplasms - secondary | Neoplasm Metastasis - drug therapy | Adult | Female | Child | Ifosfamide - therapeutic use | Busulfan - therapeutic use | Neoplasm Metastasis - radiotherapy | Etoposide - therapeutic use | Combined Modality Therapy | Lung Neoplasms - therapy | Sarcoma, Ewing - drug therapy | Sarcoma, Ewing - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Vincristine - therapeutic use | Sarcoma, Ewing - radiotherapy | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | total-lung | Klinisk medicin | Cancer and Oncology | irradiation | Cancer och onkologi
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2514 - 2520
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 8, pp. 1506 - 1514
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2011, Volume 155, Issue 2, pp. 218 - 234
Immune reconstitution appears to be delayed following myeloablative conditioning (MAC) and umbilical cord blood transplantation (UCBT) in paediatric... 
paediatrics | graft‐versus‐host disease | immune | cord blood transplantation | immunology | Graft-versus-host disease | Immunology | Immune | Paediatrics | Cord blood transplantation | NATURAL-KILLER | EX-VIVO EXPANSION | ACUTE-LEUKEMIA | ALLOGENEIC TRANSPLANTATION | INFECTIOUS COMPLICATIONS | CLINICAL-MANIFESTATIONS | UNRELATED BONE-MARROW | STEM-CELL TRANSPLANTATION | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | graft-versus-host disease | T-CELLS | Myeloablative Agonists - therapeutic use | Recombinant Proteins - therapeutic use | Whole-Body Irradiation | Antibodies, Neoplasm - therapeutic use | Cyclophosphamide - administration & dosage | Graft vs Host Disease - epidemiology | Neoplasms - surgery | Humans | Child, Preschool | Male | Antibiotic Prophylaxis | Melphalan - therapeutic use | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Busulfan - administration & dosage | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Antibodies, Monoclonal, Humanized - administration & dosage | Female | Leukocyte Count | Retrospective Studies | Transplantation Conditioning - methods | Child | Graft vs Host Disease - etiology | Antibodies, Monoclonal, Humanized - therapeutic use | Busulfan - therapeutic use | T-Lymphocytes | Neutrophils | Graft Survival | Vidarabine - analogs & derivatives | Alemtuzumab | Antibodies, Neoplasm - administration & dosage | Vidarabine - therapeutic use | Granulocyte Colony-Stimulating Factor - therapeutic use | Cord Blood Stem Cell Transplantation - methods | Melphalan - administration & dosage | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Antilymphocyte Serum | Genetic Diseases, Inborn - surgery | Vidarabine - administration & dosage | Pediatrics | Immunoglobulins | Immunotherapy | Stem cells | Transplantation | Comparative analysis | Health aspects | Index Medicus
Journal Article